サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508451

プロトンポンプ阻害薬（PPI）市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Proton Pump Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 155 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プロトンポンプ阻害薬（PPI）市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年05月31日
発行: Transparency Market Research
ページ情報: 英文 155 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プロトンポンプ阻害薬（PPI）市場- 調査範囲

TMRの調査レポート「世界のプロトンポンプ阻害薬（PPI）市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のプロトンポンプ阻害薬（PPI）市場の収益と予測を提供します。また、2024年から2034年までの世界のプロトンポンプ阻害薬（PPI）市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、プロトンポンプ阻害薬（PPI）市場を推察しました。

市場スナップショット
2023年の市場規模 37億米ドル
2034年の市場規模 56億米ドル
CAGR 4%

当レポートでは、世界のプロトンポンプ阻害薬（PPI）市場の競合情勢について調査しています。世界のプロトンポンプ阻害薬（PPI）市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のプロトンポンプ阻害薬（PPI）市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場分析と予測, 2020-2034
  • ポーターのファイブフォース分析

第5章 主要洞察

  • 規制シナリオ
  • 製品の承認/発売
  • パイプライン分析

第6章 世界市場分析と予測：薬剤タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：薬剤タイプ別, 2020-2034年
    • オメプラゾール
    • パントプラゾール
    • エソメプラゾール
    • ランソプラゾール
    • ラベプラゾール
    • その他（デキランソプラゾール等）
  • 薬剤タイプ別の市場の魅力

第7章 世界市場分析と予測：適応症タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：適応症タイプ別, 2020-2034年
    • 胃食道逆流症
    • 消化性潰瘍
  • 適応症タイプ別の市場の魅力

第8章 世界市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：エンドユーザー別, 2020-2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • エンドユーザー別の市場の魅力

第9章 世界市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 企業プロファイル
    • Pfizer
    • Teva Pharmaceutical Industries Ltd.
    • LUPIN Limited
    • Amneal Pharmaceuticals LLC
    • Zydus Cadila
    • Sun Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • Sanofi S.A.
    • AstraZeneca
図表

List of Tables

  • Table 01: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 02: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 03: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 07: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 08: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 09: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 11: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 12: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 15: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 16: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 17: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 19: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 20: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 23: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 24: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Drug Type, 2023
  • Figure 03: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Indication Type, 2023
  • Figure 04: Global Proton Pump Inhibitors (PPIs) Market Value Share, by End-user, 2023
  • Figure 05: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Region, 2023
  • Figure 06: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 07: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Drug Type, 2023
  • Figure 08: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Drug Type, 2034
  • Figure 09: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 10: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Omeprazole, 2020-2034
  • Figure 11: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Omeprazole, 2023 and 2034
  • Figure 12: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Pantaprazole, 2020-2034
  • Figure 13: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Pantaprazole, 2023 and 2034
  • Figure 14: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Esomeprazole, 2020-2034
  • Figure 15: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Esomeprazole, 2023 and 2034
  • Figure 16: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Lansoprazole, 2020-2034
  • Figure 17: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Lansoprazole, 2023 and 2034
  • Figure 18: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Rabeprazole, 2020-2034
  • Figure 19: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Rabeprazole, 2023 and 2034
  • Figure 20: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 21: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 22: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 23: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Indication Type, 2023
  • Figure 24: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Indication Type, 2034
  • Figure 25: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 26: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Gastroesophageal Reflux Disease, 2020-2034
  • Figure 27: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Gastroesophageal Reflux Disease, 2023 and 2034
  • Figure 28: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Peptic Ulcers, 2020-2034
  • Figure 29: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Peptic Ulcers, 2023 and 2034
  • Figure 30: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 31: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Distribution Channel, 2023
  • Figure 32: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Distribution Channel, 2034
  • Figure 33: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 34: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Hospitals Pharmacies, 2020-2034
  • Figure 35: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Hospitals Pharmacies, 2023 and 2034
  • Figure 36: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 37: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 38: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Online Pharmacies, 2020-2034
  • Figure 39: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Online Pharmacies, 2023 and 2034
  • Figure 40: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 41: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Region, 2023
  • Figure 42: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Region, 2034
  • Figure 43: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 44: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 45: North America Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 46: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 47: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 48: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 49: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 50: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 51: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 52: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 53: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 54: Europe Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 55: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 57: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 58: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 59: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 60: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 61: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 62: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 63: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 64: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 65: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 66: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 67: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 68: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 69: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 70: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 71: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 72: Latin America Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 73: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 74: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 75: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 76: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 77: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 78: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 79: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 80: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 81: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 82: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 83: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 84: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 85: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 86: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 87: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 88: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL19169

Proton Pump Inhibitors (PPIs) Market - Scope of Report

TMR's report on the global proton pump inhibitors (PPIs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global proton pump inhibitors (PPIs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global proton pump inhibitors (PPIs) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the proton pump inhibitors (PPIs) market.

Market Snapshot
Market Value in 2023US$ 3.7 Bn
Market Value in 2034US$ 5.6 Bn
CAGR4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global proton pump inhibitors (PPIs) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global proton pump inhibitors (PPIs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global proton pump inhibitors (PPIs) market.

The report delves into the competitive landscape of the global proton pump inhibitors (PPIs) market. Key players operating in the global proton pump inhibitors (PPIs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global proton pump inhibitors (PPIs) market profiled in this report.

Key Questions Answered in Global proton pump inhibitors (PPIs) Market Report:

  • What is the sales/revenue generated by proton pump inhibitors (PPIs) across all regions during the forecast period?
  • What are the opportunities in the global proton pump inhibitors (PPIs) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Proton Pump Inhibitors (PPIs) Market - Research Objectives and Research Approach

The comprehensive report on the global proton pump inhibitors (PPIs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global proton pump inhibitors (PPIs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global proton pump inhibitors (PPIs) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Proton Pump Inhibitors (PPIs) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, 2020-2034
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. Product Approval/Launches
  • 5.3. Pipeline Analysis

6. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2034
    • 6.3.1. Omeprazole
    • 6.3.2. Pantoprazole
    • 6.3.3. Esomeprazole
    • 6.3.4. Lansoprazole
    • 6.3.5. Rabeprazole
    • 6.3.6. Others (Dexlansoprazole, etc.)
  • 6.4. Market Attractiveness By Drug Type

7. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Indication Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Indication Type, 2020-2034
    • 7.3.1. Gastroesophageal Reflux Disease
    • 7.3.2. Peptic Ulcers
  • 7.4. Market Attractiveness By Indication Type

8. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By End-user

9. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Type, 2020-2034
    • 10.2.1. Omeprazole
    • 10.2.2. Pantoprazole
    • 10.2.3. Esomeprazole
    • 10.2.4. Lansoprazole
    • 10.2.5. Rabeprazole
    • 10.2.6. Others (Dexlansoprazole, etc.)
  • 10.3. Market Value Forecast By Indication Type, 2020-2034
    • 10.3.1. Gastroesophageal Reflux Disease
    • 10.3.2. Peptic Ulcers
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By, 2020-2034
  • 10.6. Market Value Forecast By Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Drug Type
    • 10.7.2. By Indication Type
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2034
    • 11.2.1. Omeprazole
    • 11.2.2. Pantoprazole
    • 11.2.3. Esomeprazole
    • 11.2.4. Lansoprazole
    • 11.2.5. Rabeprazole
    • 11.2.6. Others (Dexlansoprazole, etc.)
  • 11.3. Market Value Forecast By Indication Type, 2020-2034
    • 11.3.1. Gastroesophageal Reflux Disease
    • 11.3.2. Peptic Ulcers
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By, 2020-2034
  • 11.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Drug Type
    • 11.7.2. By Indication Type
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2034
    • 12.2.1. Omeprazole
    • 12.2.2. Pantoprazole
    • 12.2.3. Esomeprazole
    • 12.2.4. Lansoprazole
    • 12.2.5. Rabeprazole
    • 12.2.6. Others (Dexlansoprazole, etc.)
  • 12.3. Market Value Forecast By Indication Type, 2020-2034
    • 12.3.1. Gastroesophageal Reflux Disease
    • 12.3.2. Peptic Ulcers
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By, 2020-2034
  • 12.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. India
    • 12.6.3. Japan
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Drug Type
    • 12.7.2. By Indication Type
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2034
    • 13.2.1. Omeprazole
    • 13.2.2. Pantoprazole
    • 13.2.3. Esomeprazole
    • 13.2.4. Lansoprazole
    • 13.2.5. Rabeprazole
    • 13.2.6. Others (Dexlansoprazole, etc.)
  • 13.3. Market Value Forecast By Indication Type, 2020-2034
    • 13.3.1. Gastroesophageal Reflux Disease
    • 13.3.2. Peptic Ulcers
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By, 2020-2034
  • 13.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Drug Type
    • 13.7.2. By Indication Type
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2034
    • 14.2.1. Omeprazole
    • 14.2.2. Pantoprazole
    • 14.2.3. Esomeprazole
    • 14.2.4. Lansoprazole
    • 14.2.5. Rabeprazole
    • 14.2.6. Others (Dexlansoprazole, etc.)
  • 14.3. Market Value Forecast By Indication Type, 2020-2034
    • 14.3.1. Gastroesophageal Reflux Disease
    • 14.3.2. Peptic Ulcers
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By, 2020-2034
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. GCC
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Drug Type
    • 14.7.2. By Indication Type
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Pfizer
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Teva Pharmaceutical Industries Ltd.
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. LUPIN Limited
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. Amneal Pharmaceuticals LLC
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Zydus Cadila
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. Sun Pharmaceutical Industries Ltd.
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. Alembic Pharmaceuticals Limited
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
    • 15.2.8. Sanofi S.A.
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Business Strategies
      • 15.2.8.5. Recent Developments
    • 15.2.9. AstraZeneca
      • 15.2.9.1. Company Overview
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Business Strategies
      • 15.2.9.5. Recent Developments